戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1 eases were greater in countries adopting the policy in 2016 than in those adopting it in 2013: 23.4 percentage points (pp
2 eing viraemic were higher in partners younger than 30 years than in those aged 30 years or older (1.68, 1.35-2.09) and lo
3 015, the chewing difficulty in aged above 65 was 2.2% lower than in those aged under 65.
4 especially given that reported 3-year recurrence was higher than in those always within Milan criteria.
5 n in cells coexpressing D(1)-receptor and A(1)R-G279S(7.44) than in those coexpressing wild-type A(1)R.
6 rea of newly formed bone in specimens demineralized with CA than in those demineralized with TCN or non-demineralized (P
7 ions were more common in participants given ChAdOx1 nCoV-19 than in those given the control vaccine, and similar in natur
8 SF1 levels are higher in brown and subcutaneous fat tissues than in those in the visceral depot and that HSF1 is more abu
9 measures was lower in those who initiated ocrelizumab early than in those initially receiving placebo for most of the mea
10  cells were greater in brains inoculated with EgCME-E-I159V than in those inoculated with EgCME-WT.
11 s of Reporting Trials Statement-PRO extension (CONSORT-PRO) than in those not citing this checklist, as evidenced by the
12 ts that were significantly less fit in the lungs of WT mice than in those of neutropenic mice.
13 ing discriminability were higher in standard-reared animals than in those raised in the dark.
14 as more common in patients receiving cilofexor 100 mg (14%) than in those receiving cilofexor 30 mg (4%) and placebo (4%)
15 ores were significantly lower in patients who survived HSCT than in those receiving conventional treatment (P = .005) or
16  incidence of malaria was lower in clusters receiving rfMDA than in those receiving RACD (adjusted incidence rate ratio 0
17 0.002), and lower in clusters that received rfMDA plus RAVC than in those receiving RACD only (0.26 [0.10-0.68], p=0.006)
18 % CI 0.16-0.88], p=0.009), lower in clusters receiving RAVC than in those that did not (0.48 [0.16-0.80], p=0.002), and l
19  was more common in the villages that received azithromycin than in those that received placebo.
20 ore frequent in patients using nonbiologic systemic therapy than in those using biologics (OR = 2.84; 95% CI = 1.31-6.18)
21 articipants who had been treated with a drug-coated balloon than in those who had been treated with a standard balloon (8
22 ignificantly higher in the group that underwent TDSRF alone than in those who had combined TDSRF and PPV in the long term
23 e who receive an invasive intervention plus medical therapy than in those who receive medical therapy alone is uncertain.
24 nificantly longer in participants who received capivasertib than in those who received placebo.
25 ore than 12 times higher in patients classified as positive than in those who tested negative (adjusted hazard ratio, 12.
26 s receiving hydroxychloroquine, alone or with azithromycin, than in those who were not receiving either agent.
27 ion in patients with a normal weight (body mass index < 25) than in those who were overweight or obese (body mass index >
28 e sensitivity of the IgG ELISA was much lower in this group than in those with a multitypic profile.
29 a positive test result (4,668 of 7,178 individuals; 65.03%) than in those with a negative test result (2,436 of 11,223 pa
30 both ages were associated with higher risks of the outcomes than in those with a normal BMI at both ages.
31  mother had an onset of ZVD symptoms in the first trimester than in those with an onset during the second or third trimes
32 (39,588; 34,990-44,791 parasites/mul) and >100 times higher than in those with asymptomatic malaria (1,092; 523-2,280 par
33 2; excepting cases with evidence of perinatal brain injury) than in those with combined (19 [19%] of 98) or isolated (16
34 mic control was poorer in diabetic individuals with low SES than in those with higher SES.
35 otic resistance rates are higher in patients with urosepsis than in those with less severe infections.
36 ell inhibitory molecules are more prominent in severe cases than in those with mild disease.
37 nd were more frequently used in patients with severe asthma than in those with milder disease.
38 opulation, more deaths are expected among children with LSD than in those with MSD.
39 nts with moderate or severe vorticity (0.73 L/min +/- 0.55) than in those with none or mild vorticity (0.44 L/min +/- 0.2
40 We found that overall survival was longer in obese patients than in those with normal weight in the TCGA cohort, after ad
41 s were greater in patients with painful diabetic neuropathy than in those with painless diabetic neuropathy.
42     Cumulative symptoms in those without allergy were lower than in those with SAR but followed the pollen exposure with
43  SVRI was lower in patients with suspected bacterial sepsis than in those with severe malaria, after adjustment for hemat
44  .001) were higher among women diagnosed with breast cancer than in those without a breast cancer diagnosis.
45 scular mortality was numerically higher in patients with CA than in those without CA.
46 ate at end of treatment (EOT) was lower in patients with GC than in those without GC (P = .042); higher GC was associated
47 Is) of blood or CSF (GM 312 ng/ml; 95%CI 175-557; p<0.0001) than in those without IBIs (GM 1,439 ng/ml; 1,307-1,584; P<0.
48 iologic manifestations of immune-mediated adverse reactions than in those without radiologic manifestations (84.6% vs. 44
49 dances of Bifidobacterium and Collinsella in women with HIV than in those without.
50 tonin were higher in patients with thrombotic complications than in those without.